BDR Pharma launches generic APALUTAMIDE to treat Prostate ca

Apalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality by 35% amongst Non-Metastatic Castration resistant...

Related Keywords

India , Atmanirbhar Bharat , Raheel Shah , Business Development , Median Metastatis , Director Business Development , Honourable Prime Minister , Bdr Pharma , Bdr Pharma News , Apalutamide , Apatide , Metastatic Castration Sensitive Prostrate Cancer , Prostrate Cancer , Androgen Deprivation Therapy , ,